+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Glaucoma Market by Type, Diagnosis Method, Treatment, End-User, Age Group - Global Forecast 2025-2030- Product Image
Glaucoma Market by Type, Diagnosis Method, Treatment, End-User, Age Group - Global Forecast 2025-2030- Product Image
Sale

Glaucoma Market by Type, Diagnosis Method, Treatment, End-User, Age Group - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6017423
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Glaucoma Market grew from USD 7.23 billion in 2023 to USD 7.60 billion in 2024. It is expected to continue growing at a CAGR of 5.56%, reaching USD 10.56 billion by 2030.

Glaucoma, a progressive eye disease that damages the optic nerve and can lead to irreversible blindness, has significant market potential due to the aging global population and increasing prevalence of chronic eye conditions. The market's scope encompasses diagnostics, therapeutics, and surgical interventions with applications spanning hospitals, ophthalmology clinics, and research institutions. The necessity for effective glaucoma management stems from the critical need to prevent vision loss in millions of affected individuals, driving demand for more advanced medication and surgical techniques. End-use segments are primarily healthcare providers and research facilities focusing on innovative therapies.

Key growth factors include technological advancements in diagnostic equipment such as optical coherence tomography and new drug developments like prostaglandin analogs. The latest opportunities lie in personalized medicine approaches, telemedicine expansion, and AI-enhanced diagnostic tools that promise improved patient outcomes and streamlined care delivery. Companies are recommended to invest in R&D for minimally invasive surgical techniques and drug delivery systems, which could significantly enhance treatment efficacy and patient comfort. However, challenges such as high costs of advanced treatments, stringent regulatory requirements, and lack of awareness in some regions hinder market growth.

Limitations also include the complex pathophysiology of glaucoma, which complicates the development of universally effective treatments. To address growth barriers, strategic collaborations in AI for early detection and partnerships to enhance accessibility and affordability of care in emerging markets can be pivotal. Innovation should focus on combination therapies and neuroprotective strategies that go beyond intraocular pressure reduction. Insight into the market reveals a dynamic landscape with substantial opportunities for players who can navigate regulatory challenges and prioritize cost-effective and scalable solutions. Balancing innovation with affordability will be essential in capturing and expanding the market share in glaucoma management.

Understanding Market Dynamics in the Glaucoma Market

The Glaucoma Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising adoption of minimally invasive glaucoma surgeries contributing to market expansion
    • Increasing utilization of combination therapies in glaucoma treatment fostering market development
    • Expansion of telemedicine and remote monitoring services for glaucoma management enhancing market reach
    • Development of novel drug delivery systems for glaucoma improving patient compliance and outcomes
  • Market Restraints
    • Regulatory challenges and slow approval process affecting the introduction of new glaucoma therapies
    • Lack of awareness and education about glaucoma leading to delayed diagnosis and treatment
  • Market Opportunities
    • Revolutionizing glaucoma treatment through advanced gene therapy and personalized medicine approaches
    • Leveraging artificial intelligence and machine learning to enhance early glaucoma detection and management
    • Developing innovative and less-invasive surgical techniques for glaucoma patients to improve outcomes and recovery
  • Market Challenges
    • Lack of awareness and education on early detection of glaucoma symptoms among the general population
    • Limited availability and accessibility of specialized glaucoma care in rural and underdeveloped regions

Exploring Porter’s Five Forces for the Glaucoma Market

Porter’s Five Forces framework further strengthens the insights of the Glaucoma Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Glaucoma Market

External macro-environmental factors deeply influence the performance of the Glaucoma Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Glaucoma Market

The Glaucoma Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Glaucoma Market

The Glaucoma Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Glaucoma Market

The Glaucoma Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Glaucoma Market, highlighting leading vendors and their innovative profiles. These include Aerie Pharmaceuticals, Alcon, Allergan, Allergan (acquired by Abbvie), Bausch Health, EyeGate Pharmaceuticals, Eyenovia, Glaukos Corporation, Inotek Pharmaceuticals, Johnson & Johnson, Merck, Nicox, Novartis, Pfizer, Regeneron Pharmaceuticals, Roche, Sanofi, Santen Pharmaceutical, Teva Pharmaceutical, and Valeant Pharmaceuticals International.

Market Segmentation & Coverage

This research report categorizes the Glaucoma Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Type
    • Angle-Closure Glaucoma
    • Normal-Tension Glaucoma
    • Primary Open-Angle Glaucoma
  • Diagnosis Method
    • Gonioscopy
    • Tonometry
    • Visual Field Test
  • Treatment
    • Laser Treatment
      • Argon Laser Trabeculoplasty
      • Selective Laser Trabeculoplasty
    • Medication
      • Alpha Agonists
      • Beta Blockers
      • Carbonic Anhydrase Inhibitors
      • Prostaglandin Analogs
    • Surgery
      • Drainage Implants
      • Minimally Invasive Glaucoma Surgery
      • Trabeculectomy
  • End-User
    • Ambulatory Surgery Centers
    • Hospitals
    • Ophthalmic Clinics
    • Research Institutes
  • Age Group
    • Adult
    • Geriatric
    • Pediatric
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising adoption of minimally invasive glaucoma surgeries contributing to market expansion
5.1.1.2. Increasing utilization of combination therapies in glaucoma treatment fostering market development
5.1.1.3. Expansion of telemedicine and remote monitoring services for glaucoma management enhancing market reach
5.1.1.4. Development of novel drug delivery systems for glaucoma improving patient compliance and outcomes
5.1.2. Restraints
5.1.2.1. Regulatory challenges and slow approval process affecting the introduction of new glaucoma therapies
5.1.2.2. Lack of awareness and education about glaucoma leading to delayed diagnosis and treatment
5.1.3. Opportunities
5.1.3.1. Revolutionizing glaucoma treatment through advanced gene therapy and personalized medicine approaches
5.1.3.2. Leveraging artificial intelligence and machine learning to enhance early glaucoma detection and management
5.1.3.3. Developing innovative and less-invasive surgical techniques for glaucoma patients to improve outcomes and recovery
5.1.4. Challenges
5.1.4.1. Lack of awareness and education on early detection of glaucoma symptoms among the general population
5.1.4.2. Limited availability and accessibility of specialized glaucoma care in rural and underdeveloped regions
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Glaucoma Market, by Type
6.1. Introduction
6.2. Angle-Closure Glaucoma
6.3. Normal-Tension Glaucoma
6.4. Primary Open-Angle Glaucoma
7. Glaucoma Market, by Diagnosis Method
7.1. Introduction
7.2. Gonioscopy
7.3. Tonometry
7.4. Visual Field Test
8. Glaucoma Market, by Treatment
8.1. Introduction
8.2. Laser Treatment
8.2.1. Argon Laser Trabeculoplasty
8.2.2. Selective Laser Trabeculoplasty
8.3. Medication
8.3.1. Alpha Agonists
8.3.2. Beta Blockers
8.3.3. Carbonic Anhydrase Inhibitors
8.3.4. Prostaglandin Analogs
8.4. Surgery
8.4.1. Drainage Implants
8.4.2. Minimally Invasive Glaucoma Surgery
8.4.3. Trabeculectomy
9. Glaucoma Market, by End-User
9.1. Introduction
9.2. Ambulatory Surgery Centers
9.3. Hospitals
9.4. Ophthalmic Clinics
9.5. Research Institutes
10. Glaucoma Market, by Age Group
10.1. Introduction
10.2. Adult
10.3. Geriatric
10.4. Pediatric
11. Americas Glaucoma Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Glaucoma Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Glaucoma Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. GLAUCOMA MARKET RESEARCH PROCESS
FIGURE 2. GLAUCOMA MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL GLAUCOMA MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL GLAUCOMA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GLAUCOMA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL GLAUCOMA MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL GLAUCOMA MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2023 VS 2030 (%)
FIGURE 9. GLOBAL GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL GLAUCOMA MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 11. GLOBAL GLAUCOMA MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL GLAUCOMA MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 13. GLOBAL GLAUCOMA MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL GLAUCOMA MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
FIGURE 15. GLOBAL GLAUCOMA MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS GLAUCOMA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS GLAUCOMA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES GLAUCOMA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES GLAUCOMA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC GLAUCOMA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC GLAUCOMA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. GLAUCOMA MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. GLAUCOMA MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. GLAUCOMA MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL GLAUCOMA MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GLAUCOMA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GLAUCOMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLAUCOMA MARKET DYNAMICS
TABLE 7. GLOBAL GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GLAUCOMA MARKET SIZE, BY ANGLE-CLOSURE GLAUCOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GLAUCOMA MARKET SIZE, BY NORMAL-TENSION GLAUCOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GLAUCOMA MARKET SIZE, BY PRIMARY OPEN-ANGLE GLAUCOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GLAUCOMA MARKET SIZE, BY GONIOSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GLAUCOMA MARKET SIZE, BY TONOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GLAUCOMA MARKET SIZE, BY VISUAL FIELD TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GLAUCOMA MARKET SIZE, BY LASER TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GLAUCOMA MARKET SIZE, BY ARGON LASER TRABECULOPLASTY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GLAUCOMA MARKET SIZE, BY SELECTIVE LASER TRABECULOPLASTY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL GLAUCOMA MARKET SIZE, BY MEDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL GLAUCOMA MARKET SIZE, BY ALPHA AGONISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL GLAUCOMA MARKET SIZE, BY BETA BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL GLAUCOMA MARKET SIZE, BY CARBONIC ANHYDRASE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL GLAUCOMA MARKET SIZE, BY PROSTAGLANDIN ANALOGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL GLAUCOMA MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL GLAUCOMA MARKET SIZE, BY DRAINAGE IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL GLAUCOMA MARKET SIZE, BY MINIMALLY INVASIVE GLAUCOMA SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL GLAUCOMA MARKET SIZE, BY TRABECULECTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL GLAUCOMA MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL GLAUCOMA MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL GLAUCOMA MARKET SIZE, BY OPHTHALMIC CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL GLAUCOMA MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL GLAUCOMA MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL GLAUCOMA MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL GLAUCOMA MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS GLAUCOMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 65. CANADA GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. CANADA GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 67. CANADA GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 68. CANADA GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 69. CANADA GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 70. CANADA GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 71. CANADA GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. CANADA GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 73. MEXICO GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. MEXICO GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 75. MEXICO GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 76. MEXICO GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 77. MEXICO GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 78. MEXICO GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 79. MEXICO GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. MEXICO GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES GLAUCOMA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 90. ASIA-PACIFIC GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 92. ASIA-PACIFIC GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 94. ASIA-PACIFIC GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 96. ASIA-PACIFIC GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 98. ASIA-PACIFIC GLAUCOMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 99. AUSTRALIA GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. AUSTRALIA GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 101. AUSTRALIA GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 102. AUSTRALIA GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 103. AUSTRALIA GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 104. AUSTRALIA GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 105. AUSTRALIA GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. AUSTRALIA GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 107. CHINA GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 108. CHINA GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 109. CHINA GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 110. CHINA GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 111. CHINA GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 112. CHINA GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 113. CHINA GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. CHINA GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 115. INDIA GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 116. INDIA GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 117. INDIA GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 118. INDIA GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 119. INDIA GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 120. INDIA GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 121. INDIA GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. INDIA GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 123. INDONESIA GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. INDONESIA GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 125. INDONESIA GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 126. INDONESIA GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 127. INDONESIA GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 128. INDONESIA GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 129. INDONESIA GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. INDONESIA GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 131. JAPAN GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 132. JAPAN GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 133. JAPAN GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 134. JAPAN GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 135. JAPAN GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 136. JAPAN GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 137. JAPAN GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. JAPAN GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 139. MALAYSIA GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. MALAYSIA GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 141. MALAYSIA GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 142. MALAYSIA GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 143. MALAYSIA GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 144. MALAYSIA GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 145. MALAYSIA GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. MALAYSIA GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 147. PHILIPPINES GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. PHILIPPINES GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 149. PHILIPPINES GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 150. PHILIPPINES GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 151. PHILIPPINES GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 152. PHILIPPINES GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 153. PHILIPPINES GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. PHILIPPINES GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 155. SINGAPORE GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 156. SINGAPORE GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 157. SINGAPORE GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 158. SINGAPORE GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 159. SINGAPORE GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 160. SINGAPORE GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 161. SINGAPORE GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. SINGAPORE GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 163. SOUTH KOREA GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 164. SOUTH KOREA GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 165. SOUTH KOREA GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 166. SOUTH KOREA GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 167. SOUTH KOREA GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 168. SOUTH KOREA GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 169. SOUTH KOREA GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. SOUTH KOREA GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 171. TAIWAN GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 172. TAIWAN GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 173. TAIWAN GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 174. TAIWAN GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 175. TAIWAN GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 176. TAIWAN GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 177. TAIWAN GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 178. TAIWAN GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 179. THAILAND GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 180. THAILAND GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 181. THAILAND GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 182. THAILAND GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 183. THAILAND GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 184. THAILAND GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 185. THAILAND GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. THAILAND GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 187. VIETNAM GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 188. VIETNAM GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 189. VIETNAM GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 190. VIETNAM GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 191. VIETNAM GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 192. VIETNAM GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 193. VIETNAM GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 194. VIETNAM GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 204. DENMARK GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 205. DENMARK GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 206. DENMARK GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 207. DENMARK GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 208. DENMARK GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 209. DENMARK GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 210. DENMARK GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 211. DENMARK GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 212. EGYPT GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 213. EGYPT GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 214. EGYPT GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 215. EGYPT GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 216. EGYPT GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 217. EGYPT GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 218. EGYPT GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 219. EGYPT GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 220. FINLAND GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 221. FINLAND GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 222. FINLAND GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 223. FINLAND GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 224. FINLAND GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 225. FINLAND GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 226. FINLAND GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 227. FINLAND GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 228. FRANCE GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 229. FRANCE GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 230. FRANCE GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 231. FRANCE GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 232. FRANCE GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 233. FRANCE GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 234. FRANCE GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 235. FRANCE GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 236. GERMANY GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 237. GERMANY GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 238. GERMANY GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 239. GERMANY GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 240. GERMANY GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 241. GERMANY GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 242. GERMANY GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 243. GERMANY GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 244. ISRAEL GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 245. ISRAEL GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 246. ISRAEL GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 247. ISRAEL GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 248. ISRAEL GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 249. ISRAEL GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 250. ISRAEL GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 251. ISRAEL GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 252. ITALY GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 253. ITALY GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 254. ITALY GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 255. ITALY GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 256. ITALY GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 257. ITALY GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 258. ITALY GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 259. ITALY GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 260. NETHERLANDS GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 261. NETHERLANDS GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 266. NETHERLANDS GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 267. NETHERLANDS GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 268. NIGERIA GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 269. NIGERIA GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 270. NIGERIA GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 271. NIGERIA GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 272. NIGERIA GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 273. NIGERIA GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 274. NIGERIA GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 275. NIGERIA GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 276. NORWAY GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 277. NORWAY GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 278. NORWAY GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 279. NORWAY GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 280. NORWAY GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 281. NORWAY GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 282. NORWAY GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 283. NORWAY GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 284. POLAND GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 285. POLAND GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 286. POLAND GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 287. POLAND GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 288. POLAND GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 289. POLAND GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 290. POLAND GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 291. POLAND GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 292. QATAR GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 293. QATAR GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 294. QATAR GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 295. QATAR GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 296. QATAR GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 297. QATAR GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 298. QATAR GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 299. QATAR GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 300. RUSSIA GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 301. RUSSIA GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 302. RUSSIA GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 303. RUSSIA GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 304. RUSSIA GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 305. RUSSIA GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 306. RUSSIA GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 307. RUSSIA GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 308. SAUDI ARABIA GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 310. SAUDI ARABIA GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 312. SAUDI ARABIA GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 314. SAUDI ARABIA GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 316. SOUTH AFRICA GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 318. SOUTH AFRICA GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 320. SOUTH AFRICA GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 322. SOUTH AFRICA GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 324. SPAIN GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 325. SPAIN GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 326. SPAIN GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 327. SPAIN GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 328. SPAIN GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 329. SPAIN GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 330. SPAIN GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 331. SPAIN GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 332. SWEDEN GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 333. SWEDEN GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 334. SWEDEN GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 335. SWEDEN GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 336. SWEDEN GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 337. SWEDEN GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 338. SWEDEN GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 339. SWEDEN GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 340. SWITZERLAND GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 341. SWITZERLAND GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 342. SWITZERLAND GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 343. SWITZERLAND GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 344. SWITZERLAND GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 345. SWITZERLAND GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 346. SWITZERLAND GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 347. SWITZERLAND GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 348. TURKEY GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 349. TURKEY GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 350. TURKEY GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 351. TURKEY GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 352. TURKEY GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 353. TURKEY GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 354. TURKEY GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 355. TURKEY GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 356. UNITED ARAB EMIRATES GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 357. UNITED ARAB EMIRATES GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 358. UNITED ARAB EMIRATES GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 359. UNITED ARAB EMIRATES GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 360. UNITED ARAB EMIRATES GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 361. UNITED ARAB EMIRATES GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 362. UNITED ARAB EMIRATES GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 363. UNITED ARAB EMIRATES GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 364. UNITED KINGDOM GLAUCOMA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 365. UNITED KINGDOM GLAUCOMA MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 366. UNITED KINGDOM GLAUCOMA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 367. UNITED KINGDOM GLAUCOMA MARKET SIZE, BY LASER TREATMENT, 2018-2030 (USD MILLION)
TABLE 368. UNITED KINGDOM GLAUCOMA MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 369. UNITED KINGDOM GLAUCOMA MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 370. UNITED KINGDOM GLAUCOMA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 371. UNITED KINGDOM GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 372. GLAUCOMA MARKET SHARE, BY KEY PLAYER, 2023
TABLE 373. GLAUCOMA MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Glaucoma Market, which are profiled in this report, include:
  • Aerie Pharmaceuticals
  • Alcon
  • Allergan
  • Allergan (acquired by Abbvie)
  • Bausch Health
  • EyeGate Pharmaceuticals
  • Eyenovia
  • Glaukos Corporation
  • Inotek Pharmaceuticals
  • Johnson & Johnson
  • Merck
  • Nicox
  • Novartis
  • Pfizer
  • Regeneron Pharmaceuticals
  • Roche
  • Sanofi
  • Santen Pharmaceutical
  • Teva Pharmaceutical
  • Valeant Pharmaceuticals International

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages180
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 7.6 Billion
Forecasted Market Value ( USD ) by 2030 $ 10.56 Billion
Compound Annual Growth Rate5.5%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Glaucoma Surgery Devices Market by Product, Surgery Method, End-User - Global Forecast 2025-2030 - Product Image

Glaucoma Surgery Devices Market by Product, Surgery Method, End-User - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Glaucoma Aqueous Shunt Device Market by Material, End User, Surgery Type - Global Forecast 2025-2030 - Product Image

Glaucoma Aqueous Shunt Device Market by Material, End User, Surgery Type - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Micro Invasive Glaucoma Surgery (MIGS) Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Micro Invasive Glaucoma Surgery (MIGS) Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size, Share & Trends Analysis Report by Product (Valves, Glaucoma Drainage Implant), Surgery Method, End-use, Region, and Segment Forecast 2024-2030 - Product Image

Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size, Share & Trends Analysis Report by Product (Valves, Glaucoma Drainage Implant), Surgery Method, End-use, Region, and Segment Forecast 2024-2030

  • Report
  • 120 Pages
  • Global
From
Glaucoma Surgery Devices - Global Strategic Business Report - Product Image

Glaucoma Surgery Devices - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From

About the Market

Glaucoma is a group of eye diseases that damage the optic nerve, leading to vision loss. It is the leading cause of irreversible blindness worldwide. The glaucoma market within the optical industry is focused on providing treatments and technologies to diagnose and manage the disease. This includes medications, laser treatments, and surgical procedures. Additionally, the market includes devices such as tonometers, optical coherence tomography (OCT) systems, and visual field analyzers. These devices are used to measure intraocular pressure, detect structural changes in the eye, and assess the extent of vision loss. Companies in the glaucoma market include Allergan, Bausch + Lomb, Carl Zeiss Meditec, Ellex, Glaukos, Hoya, Nidek, Topcon, and Ziemer Ophthalmic Systems. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.